Dimensional Fund Advisors’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Dimensional Fund Advisors's AVTX Position: Q3 2026 in Review
Dimensional Fund Advisors sold out of Avalo Therapeutics (AVTX) in Q3 2026, closing a stake of 38,158 shares — an estimated $707K sold.
Dimensional Fund Advisors first reported a position in AVTX in Q3 2025 and held it in 3 quarters. The position peaked at $707K in Q2 2026. 148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Dimensional Fund Advisors reported no remaining Avalo Therapeutics position as of Q3 2026 after selling out during the quarter.
- Dimensional Fund Advisors sold 38,158 Avalo Therapeutics shares in Q3 2026, an estimated $707K.
- Dimensional Fund Advisors first reported a position in Avalo Therapeutics in Q3 2025 and held it in 3 quarters.
- Dimensional Fund Advisors's Avalo Therapeutics position peaked at $707K in Q2 2026.
- 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.